Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1976-7-6
|
| pubmed:abstractText |
Two preparations of carbamazepine, as tablets and in syrup, were given for 8 weeks to 20 patients with epilepsy in a randomized crossover study. Weekly plasma levels were 3-21 mg/1 on dosages of 5-24 mg/kg/day. There was no difference in absorption or steady-state level between the two preparations. Carbamazepine 10, 11-oxide was constantly present when the level of carbamazepine was over 5 mg/l, and tended to be lower with the syrup.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0013-9580
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
16
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
759-64
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:1222752-Administration, Oral,
pubmed-meshheading:1222752-Adult,
pubmed-meshheading:1222752-Biological Availability,
pubmed-meshheading:1222752-Carbamazepine,
pubmed-meshheading:1222752-Child,
pubmed-meshheading:1222752-Epilepsy,
pubmed-meshheading:1222752-Humans,
pubmed-meshheading:1222752-Male,
pubmed-meshheading:1222752-Suspensions,
pubmed-meshheading:1222752-Tablets,
pubmed-meshheading:1222752-Time Factors
|
| pubmed:year |
1975
|
| pubmed:articleTitle |
Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|